# Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)

> **NCT03238482** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 64 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** salmeterol-fluticasone
- **DRUG:** salmeterol-fluticasone
- **DRUG:** salmeterol-fluticasone
- **DRUG:** salmeterol-fluticasone

## Key facts

- **NCT ID:** NCT03238482
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-16
- **Primary completion:** 2017-12-19
- **Final completion:** 2017-12-19
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2018-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03238482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03238482, "Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03238482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*